CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy

Volume 13, Issue 1, December 2024 .
Source: OncoImmunology - Category: Cancer & Oncology Authors: Source Type: research